key: cord-1010669-fent52id authors: Rossi, Gemma; Zaccari, Piera; Apadula, Laura; Fanti, Lorella; Notaristefano, Chiara; Azzolini, Francesco; Viale, Edi; Esposito, Dario; Testoni, Pier Alberto; Petrone, Maria Chiara; Mariani, Alberto; Capurso, Gabriele; Arcidiacono, Paolo Giorgio title: Factors associated with the risk of patients and healthcare workers to develop COVID-19 during digestive endoscopy in a high-incidence area date: 2020-12-14 journal: Gastrointest Endosc DOI: 10.1016/j.gie.2020.07.019 sha: e1562deb7a22293b50e76ef8e2f009f28140aaf3 doc_id: 1010669 cord_uid: fent52id nan Factors associated with the risk of patients and healthcare workers to develop COVID-19 during digestive endoscopy in a high-incidence area To the Editor: We read with interest the article by Soetikno et al 1 on how to reduce the risk of COVID-19 spread among patients and healthcare workers (HCWs) during GI endoscopy. In a single-center prospective study, conducted with EC approval (Study Code GIE/COVID-19), we investigated (1) the rate of patients who experienced confirmed or probable COVID-19, according to the World Health Organization definition, after undergoing GI endoscopy and factors associated with this risk and (2) whether HCWs who took care of patients in whom COVID-19 eventually developed were at higher risk for infection. Patients were interrogated by means of a semistructured telephone questionnaire 2 weeks after the procedures; all HCWs at the endoscopy unit received serologic screening by means of a SARS-CoV-2 IgG immunoassay after a further 40 days (DiaSorin, Saluggia, Italy), and HCWs with positive results received a swab. The results are shown in Table 1 . The patients' response rate was 82.9% (537/648), and 56 patients (10.4%) experienced either probable or confirmed COVID-19. Living in high-risk areas within Lombardy (odds ratio [OR] Z 4.4), contact with suspected cases (OR Z 10), and having undergone combined EUS þ ERCP (OR Z 4.8) were independent risk factors for the development of probable or confirmed COVID-19 after logistic regression analysis. Age, comorbidities, immunosuppression, being an inpatient, and week in which the procedures were performed were not associated with COVID-19. Six out of 59 (10.1%) HCWs had positive results for SARS-CoV-2 IgG, all of them with negative swab results, and no symptoms except one. Having performed procedures on patients with COVID-19 (P Z .12) and number of contacts with patients in whom COVID-19 developed were not associated with seropositivity (c 2 for trend, P Z .69). These findings are in keeping with recent data reporting that COVID-19 development after GI endoscopy is uncommon, 2 and they suggest that it seems mainly due to environmental factors. Whether combined EUS þ ERCP convey an increased risk deserves further investigation. There seemed to be no evidence of increased contagion risk among HCWs during the procedure. Addressing unmet needs of gastroenterologists' training in the post-COVID-19 era Considerations in performing endoscopy during the COVID-19 pandemic Low risk of covid-19 transmission in GI endoscopy